Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 17/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7680790 | 0.94 | CRHR1 (0.88) | CRHR1MAPTPIK3CBPIK3CAMTOR | |
| SCHEMBL9110881 | 0.92 | CRHR1 (0.85) | CRHR1MAPTPIK3CBPIK3CAMTOR | |
| SCHEMBL7680357 | 0.84 | CRHR1 (0.72) | CRHR1MAPTPIK3CBPIK3CAMTOR | |
| SCHEMBL7687498 | 0.79 | CRHR1 (0.82) | CRHR1 | |
| SCHEMBL7686975 | 0.76 | CRHR1 (1.00) | CRHR1 | |
| SCHEMBL7678150 | 0.76 | CRHR1 (0.61) | CRHR1MAPTPIK3CA | |
| SCHEMBL7680488 | 0.73 | CRHR1 (0.72) | CRHR1 | |
| SCHEMBL7684475 | 0.68 | CRHR1 (0.84) | CRHR1 | |
| SCHEMBL6775265 | 0.67 | CRHR1 (0.51) | CRHR1MAPTPIK3CBPIK3CA | |
| SCHEMBL8208007 | 0.67 | CRHR1 (1.00) | CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995010506-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-20 | — | — | WO | claimed |
| US-6342503-B1 | ANTIDEPRESSANTS, EATING DISORDERS | DUPONT PHARMACEUTICALS COMPANY | 2002-01-29 | — | — | US | disclosed |
| US-6107301-A | PSYCHOLOGICAL DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-08-22 | — | — | US | disclosed |
| WO-1995010506-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-20 | — | — | WO | disclosed |